Pharma Journalist 9038 posts 0 comments

Sedor Pharmaceuticals, LLC (Sedor) announced that the U.S. Food and Drug Administration (FDA) has approved SESQUIENT (fosphenytoin sodium for injection) for the treatment of status…
Read More...

The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for Eli Lilly and Company's investigational neutralizing antibody bamlanivimab (LY-CoV555) 700 mg.…
Read More...

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, announced that an independent…
Read More...

Amgen and AstraZeneca announced positive topline results from the Phase 3 NAVIGATOR trial in which the investigational medicine tezepelumab demonstrated a statistically significant…
Read More...

AstraZeneca’s Calquence (acalabrutinib), a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European Union (EU) for the treatment of adult…
Read More...

Vifor Pharma and Angion Biomedica Corp. (Angion) announced the signing of a licensing agreement for the commercialization of ANG-3777, currently being developed for treatment of delayed…
Read More...

Ultragenyx Pharmaceutical Inc. a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare genetic diseases, announced that it…
Read More...

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of…
Read More...

On November 9, 2020, Bridge Biotherapeutics (288330 KQ) reported to the Korea Stock Exchange that the Company and Boehringer Ingelheim have mutually agreed on the termination of the…
Read More...

ImmunityBio, Inc. a privately-held, clinical-stage immunotherapy company, announced positive study results for their human Ad5 (hAd5) COVID-19 vaccine candidate, which shows memory…
Read More...